Evidence map›Paper›PMID 32150054›Full record

ArticleMedicine2020

A multicenter retrospective investigation on the efficacy of perioperative oral management in cancer patients.

Shin-Ichi Yamada, Sakiko Soutome, Takumi Hasegawa, Itaru Tojyo, Hirokazu Nakahara, Mao Kawakami, Marina Hirose, Shigeyuki Fujita, Takahide Komori, Tadaaki Kirita and 3 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Number of Bacteria in Saliva in the Perioperative Period and Factors Associated with Increased Numbers.International journal of environmental research and public health · 2022
    Article
  9. Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Shin-Ichi YamadaDepartment of Dentistry and Oral Surgery, Shinshu University School of Medicine. Matsumoto.
Sakiko SoutomeDepartment of Clinical Oral Oncology, Unit of Translational Medicine, Course of Medical and Dental Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki.
Takumi HasegawaDepartment of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine, Kobe.
Itaru TojyoDepartment of Oral and Maxillofacial Surgery, Wakayama Medical University, Wakayama.
Hirokazu NakaharaDepartment of Dentistry and Oral Surgery, Osaka City University Graduate School of Medicine, Osaka City.
Mao KawakamiDepartment of Oral and Maxillofacial Surgery, Nara Medical University, Kashihara.
Marina HiroseDepartment of Oral and Maxillofacial Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Shigeyuki FujitaDepartment of Oral and Maxillofacial Surgery, Wakayama Medical University, Wakayama.
Takahide KomoriDepartment of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine, Kobe.
Tadaaki KiritaDepartment of Oral and Maxillofacial Surgery, Nara Medical University, Kashihara.
Yasuyuki ShibuyaDepartment of Oral and Maxillofacial Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Masahiro UmedaDepartment of Clinical Oral Oncology, Unit of Translational Medicine, Course of Medical and Dental Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki.
Hiroshi KuritaDepartment of Dentistry and Oral Surgery, Shinshu University School of Medicine. Matsumoto.
Kobe University · JPNagasaki University · JPNagoya City University · JPNara Medical University · JPShinshu University · JPWakayama Medical University · JPOsaka City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients develop a number of oral complications during cancer treatments. Oral bacteria are associated with the onset of dental focal infections and the progression of oral mucositis. Dental focal infections are frequently associated with the systemic onset of bacteremia, sepsis, and pneumonia. The degeneration of oral function with these complications may become an obstacle to cancer treatments. Although comprehensive oral management, including oral care, the removal of dental focal infections, and improvements in oral function with dentures, is conducted for cancer patients in Japan, few studies have assessed its efficacy.The aim of the present study was to investigate the incidence of dental/oral complications in cancer patients with perioperative oral managements (POMs) based on a large number of case series with a multicenter retrospective analysis.The medical records of cancer patients with POMs were retrospectively reviewed and the incidence of oral complications and efficacy of oral management were investigated.A total of 2744 cancer patients with POMs (1684 males and 1080 females, mean age 65.9 ± 13.0 years) were included and investigated in the present study. Among these patients, 2097 (76.4%) started POM before the initiation of cancer treatments, with 2130 (77.6%) receiving oral care only and 391 (14.2%) being subjected to invasive treatments, such as tooth extraction. The incidence of dental focal infections during the period of cancer treatments was 8.2%. The most frequent infection was acute periodontitis, including alveolar abscesses (112 patients, 4.1%). The incidence of grade 2 and 3 oral mucositis was 2.8%. Prolonged fever was observed in 113 patients (4.1%), with 7 having dental focal infections (6.2%). These incidence rates were lower than those reported previously.Based on analyses of a large number of patients, the present results support the efficacy of oral management in cancer patients. However, further studies are needed to establish adequate oral management guidelines for cancer patients.

Indexed as

AdolescentAdultAgedAged, 80 and overAntineoplastic AgentsChildChild, PreschoolFemaleHumansIncidenceInfantInfant, NewbornJapanMaleMiddle AgedNeoplasmsAntineoplastic Agents

Identifiers

PMID32150054
PMCPMC7478406
OpenAlexW3011894746

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.